Browse by all authors Browse By Author ID - Fassett, Robert G.

Browse Results (193 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 4

Result Pages:    1 2 3 4  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Mc Naughton, L., Wakefield, G., Fassett, R. and Bentley, D. (2001) A comparison of lactate kinetics, minute ventilation and acid-base balance as measures of the anaerobic threshold. Journal of Human Movement Studies, 41 4: 247-261. 187   0 Cited 1 times in Scopus1
Dagher, H., Buzza, M., Colville, D., Jones, C., Powell, H., Fassett, R., Wilson, D., Agar, J. and Savige, J. (2001) A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome. American Journal of Kidney Diseases, 38 6: 1217-1228. doi:10.1053/ajkd.2001.29217 47   35 Cited 38 times in Scopus38 0
Schrier, R. W. and Fassett, R. G. (1998) A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney International, 53 5: 1111-1117. doi:10.1046/j.1523-1755.1998.00864.x 54   21 Cited 30 times in Scopus30 0
Austen, S. K., Fletcher, L. A., Fassett, R. G., Booth, C. and Coombes, J. S. (2005) Acute exposure to cyclosporine does not increase plasma homocysteine in rats. Transplantation Proceedings, 37 10: 4543-4546. doi:10.1016/j.transproceed.2005.11.012 66   1 Cited 1 times in Scopus1 0
Austen, S., Coombes, J. S., Fletcher, L. A., Fassett, R. and Booth, C. (2002). Acute exposure to cyclosprine A does not increase plasma homocysteine in rats. In: W. W. Parmley, Journal of The American College of Cardiology: Abstracts of World Congress of Cardiology. , Sydney, (392B). 5-9 May, 2002. 61  
White, J. and Fassett, R. (1983) Acute renal failure and coagulopathy after snakebite. Medical Journal of Australia, 2 3: 142-143. 58   20 Cited 7 times in Scopus7
Lexis, L. A., Fassett, R. G. and Coombes, J. S. (2006) alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated rats. Basic & Clinical Pharmacology & Toxicology, 98 1: 68-73. doi:10.1111/j.1742-7843.2006.pto_222.x 145   21 Cited 30 times in Scopus30 0
Fassett, Matthew J., Hannan, Terry J., Robertson, Iain K., Bollipo, Steven J. and Fassett, Robert G. (2007) A national survey of medical morning handover report in Australian hospitals. Medical Journal of Australia, 187 3: 164-165. 89   14 Cited 13 times in Scopus13
Fassett, Matthew J., Hannan, Terry J., Robertson, Iain K., Bollipo, Steven J. and Fassett, Robert G. (2007) A national survey of medical morning handover report in Australian hospitals - Reply. Medical Journal of Australia, 187 10: 595-596. 85   1 Cited 4 times in Scopus4
Fassett, R., Blackhall, M. L. and Coombes, J. S. (2004). Antioxidant supplementation, cyclosporine and glomerular filtration rate in renal transplant recipients. In: W.G. Couser, Journal of the American Society of Nephrology: Abstract Issue of the 2004 Annual Meeting of the American Society of Nephrology. American Society of Nephrology Renal Week 2004, St Louis, MO, U.S.A., (300A-300A). 27 October - 1 November, 2004. 88  
Lexis, L. A., Fenning, A., Brown, L., Fassett, R. G. and Coombes, J. S. (2006) Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction. American Journal of Transplantation, 6 1: 41-49. doi:10.1111/j.1600-6143.2005.01154.x 64   20 Cited 20 times in Scopus20 0
Coombes, Jeff S. and Fassett, Robert G. (2012) Antioxidant therapy in hemodialysis patients: A systematic review. Kidney International, 81 3: 233-246. doi:10.1038/ki.2011.341 58   23 Cited 26 times in Scopus26 1
Fassett, R. G., Buttfield, I., Milazzo, S. and Pugsley, D. J. (1982). A prospective study of musculoskeletal complications of renal transplantation. In: Australasian Society of Nephrology, Sydney, Australia, (357-357). 25-27 February 1982. 34   0
Ranganathan,Dwarakanathan, John, George T., Healy, Helen, Roberts, Matthew J., Fassett, Robert G., Lipman, Jeffrey, Kubler, Paul, Ungerer, Jacobus, McWhinney, Brett C., Lim, Aaron, Purvey, Megan, Reyaldeen, Reza and Roberts, Jason A. (2013) A protocol for the pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN): An open-label, randomised controlled trial. BMJ Open, 3 8: . doi:10.1136/bmjopen-2013-003511 45   0 Cited 0 times in Scopus0 1
Cooper, Bruce A., Branley, Pauline, Bulfone, Liliana, Collins, John F., Craig, Jonathan C., Fraenkel, Margaret B., Harris, Anthony, Johnson, David W., Kesselhut, Joan, Li, Jing Jing, Luxton, Grant, Pilmore, Andrew, Tiller, David J., Harris, David C., Pollock, Carol A., IDEAL Study Group, Fassett, R. and Healy, H. (2010) A randomized, controlled trial of early versus late initiation of dialysis. New England Journal of Medicine, 363 7: 609-619. doi:10.1056/NEJMoa1000552 106   225 Cited 267 times in Scopus267 35
Johnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., HERO Study Collaborative Group and Fassett, Rob (2015) A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 1: 49-57. doi:10.1053/j.ajkd.2014.06.020 27   0 Cited 0 times in Scopus0 1
Kolade, O.O., O'Moore-Sullivan, T.M., Stowasser, M., Coombes, J.S., Fassett, R.G., Marwick, T.H. and Sharman, J.E. (2012) Arterial stiffness, central blood pressure and body size in health and disease. International Journal of Obesity, 36 1: 93-99. doi:10.1038/ijo.2011.79 92   6 Cited 9 times in Scopus9 1
Fassett, Robert G., D'Intini, Vincent, Healy, Helen, Gowardman, John, Gan, Jay-Sen, Sharman, James E . and Coombes, Jeff S. (2009) Assessment of arterial stiffness, oxidative stress and inflammation in acute kidney injury. BMC Nephrology, 10 15: Article number 15. doi:10.1186/1471-2369-10-15 99   4 Cited 7 times in Scopus7 0
Fassett, Robert G. and Coombes, Jeff S. (2011) Astaxanthin: A potential therapeutic agent in cardiovascular disease. Marine Drugs, 9 3: 447-465. doi:10.3390/md9030447 90   34 Cited 41 times in Scopus41 5
Fassett, Robert G. and Coombes, Jeff S. (2012) Astaxanthin in cardiovascular health and disease. Molecules, 17 2: 2030-2048. doi:10.3390/molecules17022030 70   14 Cited 17 times in Scopus17 1
Fassett, Robert G. and Coombes, Jeff S. (2009) Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiology, 5 4: 333-342. doi:10.2217/fca.09.19 201   Cited 49 times in Scopus49 8
Fassett, Robert G., Driver, Ritza, Healy, Helen, Robertson, Iain K., Geraghty, Dominic P., Sharman, James E. and Coombes, Jeff S. (2008) Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflamation in renal transplant patients (Xanthin): A randomised controlled trial. BMC Nephrology, 9 1: 17.1-17.8. doi:10.1186/1471-2369-9-17 115   8 Cited 16 times in Scopus16 0
Scarlett, J. D., Williamson, H. G., Dadson, P. J., Fassett, R. and Peel, M. M. (1991) A syndrome resembling thrombotic thrombocytopenic purpura associated with Capnocytophaga canimorsus septicemia. American Journal of Medicine, 90 1: 127-128. doi:10.1016/0002-9343(91)90517-2 37   18 Cited 12 times in Scopus12 0
Fassett, R.G., Ball, M.J., Robertson, I.K., Geraghty, D.P. and Coombes, J.S. (2008). Atorvastatin and the progression of chronic kidney disease: The LORD Trial. In: E. G. Neilson, Journal of the American Society of Nephrology. The American Society of Nephrology Conference, Philadelphia, PA, USA, (543A). 4-9 Nov 2008. 79  
Fassett, R. G., Ball, M. J., Robertson, I. K., Geraghty, D. P. and Coombes, J. S. (2008). Atorvastatin and the progression of chronic kidney disease: The Lord Trial. In: A. Butt, Proceedings of the Australian Health and Medical Research Congress 2008. Australian Health and Medical Research Congress 2008, Brisbane, Qld, Australia, (165-165). 16 - 21 November, 2008. 53  
Fassett, RG, Robertson, IK, Ball, MJ, Geraghty, DP and Coombes, JS (2011). Atorvastatin Improves Kidney Function in Chronic Kidney Disease Patients Undertaking High Intensity Exercise. In: 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. ANZSN 2011: 47th Annual Scientific Meeting Australian and New Zealand Society of Nephrology, Adelaide, SA, Australia, (41-41). 19-21 September 2011. doi:10.1111/j.1440-1797.2011.01490.x 40   0 0
Fassett, RG, Robertson, IK, Ball, MJ, Geraghty, DP and Coombes, JS (2011). Atorvastatin Slows the Progression of Ckd in Patients with Inflammation. In: 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. ANZSN 2011: 47th Annual Scientific Meeting Australian and New Zealand Society of Nephrology, Adelaide, SA, Australia, (40-41). 19-21 September 2011. doi:10.1111/j.1440-1797.2011.01490.x 52   0 0
Fassett, RG, Ball, MJ, Robertson, I.K., Geraghty, D.P. and Coombes, J.S. (2006) Baseline serum lipids and renal function in chronic kidney disease patients entering the LORD trial. International Journal of Clinical Pharmacology And Therapeutics, 44 11: 580-588. 156   6 Cited 5 times in Scopus5
Bulmer, A. C., Coombes, J. S., Blanchfield, J. T., Toth, I., Fassett, R. G. and Taylor, S. M. (2011) Bile pigment phamacokinetics and absorption in the rat: Therapeutic potential for enteral administration. British Journal of Pharmacology, 164 7: 1857-1870. doi:10.1111/j.1476-5381.2011.01413.x 85   15 Cited 15 times in Scopus15 0
Gobe, Glenda C., Fassett, Robert G. and Coombes, Jeff S. (2011). Bioactive nutritional supplements for chronic kidney disease: potential cost benefits. In Ronald Ross Watson, Joe K. Gerald and Victor R. Preedy (Ed.), Nutrients, dietary supplements, and nutriceuticals: Cost analysis versus clinical benefits (pp. 301-314) New York, United States: Springer. doi:10.1007/978-1-60761-308-4 77   0 0
Fassett, Robert G., Venuthurupalli, Sree K., Gobe, Glenda C., Coombes, Jeff S., Cooper, Matthew A. and Hoy, Wendy E. (2011) Biomarkers in chronic kidney disease: A review. Kidney International, 80 8: 806-821. doi:10.1038/ki.2011.198 84   67 Cited 80 times in Scopus80 1
Fassett, R. G., Fazzelari, N., McClure, J. and Pugsley, D. J. (1984). Bone disease (BD) after renal transplantation (Tx). In: Australasian Society of Nephrology, Surfers Paradise, Australia, (229-229). 29 February - 2 March 1984. 26   0
Fassett, R. G., Lien, J. W. K., Mathew, T. H. and McClure, J. (1982) Bone disease in analgesic nephropathy. Clinical Nephrology, 18 6: 273-279. 38   6 Cited 2 times in Scopus2
Fassett, R. G., Lien, J., Fazzalari, N., McClure, J. and Mathew, T. H. (1982). Bone disease in chronic renal failure due to analgesic nephropathy. In: Australasian Society of Nephrology, Sydney, Australia, (356-356). 25-27 February 1982. 34   0
McClure, J., Fazzalari, N. L., Fassett, R. G. and Pugsley, D. J. (1983) Bone histoquantitative findings and histochemical staining reactions for aluminium in chronic renal failure patients treated with haemodialysis fluids containing high and low concentrations of aluminium. Journal of Clinical Pathology, 36 11: 1281-1287. doi:10.1136/jcp.36.11.1281 29   13 Cited 5 times in Scopus5 0
Fassett, R.G., Driver, R., Healy, H. and Coombes, J.S. (2009) Cardiovascular disease in peritoneal dialysis patients. Panminerva Medica, 51 3: 151-161. 77   4 Cited 4 times in Scopus4
Sharman, J.E., Stowasser, M., Fassett, R.G., Marwick, T.H. and Franklin, S.S. (2008) Central blood pressure measurement may improve risk stratification. Journal of Human Hypertension, 22 12: 838-844. doi:10.1038/jhh.2008.71 80   29 Cited 35 times in Scopus35 1
McClure, J., Fazzalari, N. L., Fassett, R. G. and Pugsley, P. G. (1984) Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid. Journal of Clinical Pathology, 37 7: 743-747. doi:10.1136/jcp.37.7.743 33   10 Cited 0 times in Scopus0 0
Shaw, E., Colville, D., Wang, Y. Y., Dagher, H., Fassett, R. and Savige, J. (2003). Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. In: 36th Annual Meeting of the American Society of Nephrology, San Diego, California, (115A-115A). 12-17 November 2003. 33   0
Colville, D. J., Shaw, A., Wang, Y., Dagher, H., Fassett, R. and Savige, J. (2005). Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. In: ARVO Meeting Abstracts. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO 2005), Ft Lauderdale, Florida, USA, (S3297-S3297). 1-5 May 2005. 28   0
Shaw, Elizabeth A., Colville, Deb, Wang, Yan Yan, Zhang, Ke Wei, Dagher, Hayat, Fassett, Rob, Guymer, Robyn and Savige, Judy (2007) Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. Nephrology Dialysis Transplantation, 22 1: 104-108. doi:10.1093/ndt/gfl607 53   15 Cited 18 times in Scopus18 0
Healy, H., Salisbury, A., Wang, Z., Mallett, A., Huynh, S., Mohandas, T., Sanghi, P., Heffernan, D., Fassett, R. and Hoy, W. (2013). Chronic kidney disease (CKD) is not renal replacement therapy (RRT): the CKD.QLD registry dataset. In: Abstracts of the 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD, Australia, (33-34). 9-11 September 2013. doi:10.1111/nep.12121 26   0 0
Healy, Helen, Wang, Zaimin, Mallett, Andrew, Huynh, Sonny, Coleman, Sonya, Kark, Adrian, Salisbury, Anne, Venuthurupalli, Sree Krishna, Fassett, Robert and Hoy, Wendy (2013). Chronic kidney disease is a different population: the CKD. Qld registry dataset. In: Abstracts for the RACP Future Directions in Health Congress 2013. The Royal Australasian College of Physicians Future Directions in Health Congress 2013 (RACP), Perth WA, Australia, (42-42). 26-29 May 2013. doi:10.1111/imj.12150 78   0 0
Boon, Ai-Ching, Bulmer, Andrew C., Coombes, Jeff S. and Fassett, Robert G. (2014) Circulating bilirubin and defense against kidney disease and cardiovascular mortality: Mechanisms contributing to protection in clinical investigations. American Journal of Physiology - Renal Physiology, 307 2: F123-F136. doi:10.1152/ajprenal.00039.2014 23   4 Cited 2 times in Scopus2 1
Fassett, R., Salisbury, A., Banney, C., Cherian, R., Wang, Z. and Hoy, W. (2013). CKD patient profiles from a regional Queensland health renal clinic and outcomes after one year. CKD.QLD registry. In: Abstracts of the 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD, Australia, (60-61). 9-11 September 2013. doi:10.1111/nep.12121 33   0 0
Venuthurupalli, Sree K., Hoy, Wendy E., Healy, Helen G., Salisbury, Anne and Fassett, Robert G. (2012) CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia. Nephrology Dialysis Transplantation, 27 SUPPL. 3: 139-145. doi:10.1093/ndt/gfs258 69   6 Cited 7 times in Scopus7 0
Venuthurupalli, S. K., Salisbury, A., Hoy, W. E., Healy, H. and Fassett, R. G. (2011). Ckd.Qld phase 2 survey: Risk factor modification for prevention of progression of chronic kidney disease. In: 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide, Australia, (37-37). 19-21 September 2011. doi:10.1111/j.1440-1797.2011.01490.x 50   0 0
Lancashire, W., Hore, C. and Fassett, R.G. (2009) Clinical supervision by consultants in teaching hospitals. Medical Journal of Australia, 191 4: 220-222. 63   8 Cited 9 times in Scopus9
ShingCM, BrownL, Fassett, R.G., LexisLA and CoombesJS (2009). Comparison of four commonly used immunosuppress ants on vascular function, oxidative stress and inflammation in vitro. In: Nephrology: Abstracts of the 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Tasmania, Australia, (A53-A53). 7–9 September, 2009. doi:10.1111/j.1440-1797.2009.01176.x 45   0 0
Fassett, Robert G., Driver, Ritza, Healy, Helen, Ranganathan, Dwarakanathan, Ratanjee, Sharad, Robertson, Iain K., Geraghty, Dominic P., Sharman, James E. and Coombes, Jeff S. (2009) Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients: An observational study. BMC Nephrology, 10 Article No 8: xx-xx. doi:10.1186/1471-2369-10-8 84   7 Cited 11 times in Scopus11 0

Page 1 of 4

Result Pages:    1 2 3 4  next › last »